Literature DB >> 28131624

Involvement of PKCα and ERK1/2 signaling pathways in EGCG's protection against stress-induced neural injuries in Wistar rats.

Xiaoling Zhao1, Fengqin Liu2, Haimin Jin3, Renjia Li3, Yonghui Wang1, Wanqi Zhang4, Haichao Wang5, Weiqiang Chen6.   

Abstract

Stress-induced neural injuries are closely linked to the pathogenesis of various neuropsychiatric disorders and psychosomatic diseases. We and others have previously demonstrated certain protective effects of epigallocatechin-3-gallate (EGCG) in stress-induced cerebral impairments, but the underlying protective mechanisms still remain poorly elucidated. Here we provide evidence to support the possible involvement of PKCα and extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathways in EGCG-mediated protection against restraint stress-induced neural injuries in rats. In both open-field and step-through behavioral tests, the restraint stress-induced neuronal impairments were significantly ameliorated by administration of EGCG or green tea polyphenols (GTPs), which was associated with a partial restoration of normal plasma glucocorticoid, dopamine and serotonin levels. Furthermore, the stress-induced decrease of PKCα and ERK1/2 expression and phosphorylation was significantly attenuated by EGCG and to a less extent by GTP administration. Additionally, EGCG supplementation restored the production of adenosine triphosphate (ATP) and the expression of a key regulator of cellular energy metabolism, the peroxisome proliferators-activated receptor-γ coactivator-1α (PGC-1α), in stressed animals. In conclusion, PKCα and ERK1/2 signaling pathways as well as PGC-1α-mediated ATP production might be involved in EGCG-mediated protection against stress-induced neural injuries.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  epigallocatechin-3-gallate (EGCG); extracellular signal-regulated kinase1/2 (ERK1/2); peroxisome proliferators-activated receptor-γ coactivator-1 α (PGC-1α); protein kinase C α (PKCα); stress

Mesh:

Substances:

Year:  2017        PMID: 28131624      PMCID: PMC5421386          DOI: 10.1016/j.neuroscience.2017.01.025

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  97 in total

1.  Specific induction of metallothionein synthesis by mitochondrial oxidative stress.

Authors:  M Kondoh; Y Inoue; S Atagi; N Futakawa; M Higashimoto; M Sato
Journal:  Life Sci       Date:  2001-09-21       Impact factor: 5.037

2.  Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.

Authors:  L Reznichenko; T Amit; H Zheng; Y Avramovich-Tirosh; M B H Youdim; O Weinreb; S Mandel
Journal:  J Neurochem       Date:  2006-03-15       Impact factor: 5.372

Review 3.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

4.  A role for peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1) in the regulation of cardiac mitochondrial phospholipid biosynthesis.

Authors:  Ling Lai; Miao Wang; Ola J Martin; Teresa C Leone; Rick B Vega; Xianlin Han; Daniel P Kelly
Journal:  J Biol Chem       Date:  2013-12-11       Impact factor: 5.157

5.  Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

Authors:  Julie St-Pierre; Stavit Drori; Marc Uldry; Jessica M Silvaggi; James Rhee; Sibylle Jäger; Christoph Handschin; Kangni Zheng; Jiandie Lin; Wenli Yang; David K Simon; Robert Bachoo; Bruce M Spiegelman
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

6.  Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression.

Authors:  A Thorsell; M Michalkiewicz; Y Dumont; R Quirion; L Caberlotto; R Rimondini; A A Mathé; M Heilig
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

7.  Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.

Authors:  Zhiyong Hong; Yongquan Xu; Jun-Feng Yin; Jianchang Jin; Yongwen Jiang; Qizhen Du
Journal:  J Agric Food Chem       Date:  2014-12-17       Impact factor: 5.279

Review 8.  Metabolism of green tea catechins: an overview.

Authors:  Wan Yong Feng
Journal:  Curr Drug Metab       Date:  2006-10       Impact factor: 3.731

9.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

Authors:  Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph D Buxbaum; Giulio M Pasinetti
Journal:  Arch Neurol       Date:  2009-03

10.  Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma.

Authors:  Caroline Menard; Stéphane Bastianetto; Rémi Quirion
Journal:  Front Cell Neurosci       Date:  2013-12-26       Impact factor: 5.505

View more
  11 in total

1.  SPP1 promotes Schwann cell proliferation and survival through PKCα by binding with CD44 and αvβ3 after peripheral nerve injury.

Authors:  Jiang-Bo Wang; Zhan Zhang; Jian-Nan Li; Tuo Yang; Shuang Du; Rang-Juan Cao; Shu-Sen Cui
Journal:  Cell Biosci       Date:  2020-08-20       Impact factor: 7.133

2.  Epigallocatechin-3-gallate confers protection against corticosterone-induced neuron injuries via restoring extracellular signal-regulated kinase 1/2 and phosphatidylinositol-3 kinase/protein kinase B signaling pathways.

Authors:  Xiaoling Zhao; Renjia Li; Hui Jin; Haimin Jin; Yonghui Wang; Wanqi Zhang; Haichao Wang; Weiqiang Chen
Journal:  PLoS One       Date:  2018-01-26       Impact factor: 3.240

Review 3.  Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases.

Authors:  Monira Pervin; Keiko Unno; Tomokazu Ohishi; Hiroki Tanabe; Noriyuki Miyoshi; Yoriyuki Nakamura
Journal:  Molecules       Date:  2018-05-29       Impact factor: 4.411

Review 4.  Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases.

Authors:  Shu-Qing Chen; Ze-Shi Wang; Yi-Xiao Ma; Wei Zhang; Jian-Liang Lu; Yue-Rong Liang; Xin-Qiang Zheng
Journal:  Molecules       Date:  2018-02-25       Impact factor: 4.411

Review 5.  A Comprehensive Insight on the Health Benefits and Phytoconstituents of Camellia sinensis and Recent Approaches for Its Quality Control.

Authors:  Maram M Aboulwafa; Fadia S Youssef; Haidy A Gad; Ahmed E Altyar; Mohamed M Al-Azizi; Mohamed L Ashour
Journal:  Antioxidants (Basel)       Date:  2019-10-06

Review 6.  Protein Kinase C Isozymes and Autophagy during Neurodegenerative Disease Progression.

Authors:  Humeyra Nur Kaleli; Ebru Ozer; Veysel Ogulcan Kaya; Ozlem Kutlu
Journal:  Cells       Date:  2020-02-27       Impact factor: 6.600

7.  Regulation of PGC-1α mediated by acetylation and phosphorylation in MPP+ induced cell model of Parkinson's disease.

Authors:  Fei Fan; Songlin Li; Zhipeng Wen; Qiaoyue Ye; Xiaochun Chen; Qinyong Ye
Journal:  Aging (Albany NY)       Date:  2020-05-26       Impact factor: 5.682

8.  ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication.

Authors:  Zi-Yu Wang; Yu-Qi Li; Zhi-Wei Guo; Xing-Hao Zhou; Mu-Dan Lu; Tong-Chun Xue; Bo Gao
Journal:  Acta Pharmacol Sin       Date:  2019-09-25       Impact factor: 6.150

Review 9.  Putative role of natural products as Protein Kinase C modulator in different disease conditions.

Authors:  Rishi Kant Singh; Sanjay Kumar; Munendra Singh Tomar; Praveen Kumar Verma; Amit Kumar; Sandeep Kumar; Naveen Kumar; Jai Prakash Singh; Arbind Acharya
Journal:  Daru       Date:  2021-07-03       Impact factor: 4.088

Review 10.  New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases.

Authors:  Marco T Nuñez; Pedro Chana-Cuevas
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.